Cancer

Lenvima approved for common thyroid cancer

(HealthDay)—Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in ...

Feb 13, 2015
popularity 5 / 5 (1) | comments 0

New studies quantify morcellation's link to uterine cancer

The dangers of a power tool used in gynecological surgery have been debated for more than a year, with experts offering varying estimates of the chance that an undetected uterine cancer would be spread - and likely worsened ...

Feb 23, 2015
popularity 5 / 5 (1) | comments 0

'Patchwork' ovarian cancer more deadly

The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a Cancer Research UK study published today (Tuesday) in PLOS Medicine.

Feb 24, 2015
popularity 5 / 5 (1) | comments 0